Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.
about
Combined hepatocellular cholangiocarcinoma: Controversies to be addressedGenetic profiling of intrahepatic cholangiocarcinomaPathology of intrahepatic cholangiocarcinoma.Human tumor microRNA signatures derived from large-scale oligonucleotide microarray datasets.Risk factors for combined hepatocellular-cholangiocarcinoma: a hospital-based case-control studySilencing of miR-370 in human cholangiocarcinoma by allelic loss and interleukin-6 induced maternal to paternal epigenotype switchMolecular pathology of hepatic neoplasms: classification and clinical significance.Liver cancer oncogenomics: opportunities and dilemmas for clinical applications.Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma.A genetic database can be utilized to identify potential biomarkers for biphenotypic hepatocellular carcinoma-cholangiocarcinoma.Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma.Pathology of combined hepatocellular-cholangiocarcinoma.Combined hepatocellular and cholangiocarcinoma associated with hepatolithiasis: report of a case.Hepatic progenitor cells: their role and functional significance in the new classification of primary liver cancers.Molecular pathogenesis of intrahepatic cholangiocarcinoma.Current update on combined hepatocellular-cholangiocarcinoma.Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss.microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer.Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma.The 6th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2015): Evidence and Consensus on HCC Management.Ectonucleoside triphosphate diphosphohydrolase type 5 (Entpd5)-deficient mice develop progressive hepatopathy, hepatocellular tumors, and spermatogenic arrest.Acquisition of Cholangiocarcinoma Traits during Advanced Hepatocellular Carcinoma Development in Mice.Histological heterogeneity in primary and metastatic classic combined hepatocellular-cholangiocarcinoma: a case series.MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma.Frequent intragenic rearrangements of DPYD in colorectal tumours
P2860
Q26749446-603A51E7-416C-45EE-AD6D-0405E89E3431Q27005787-89DAAFFB-556B-4913-97A7-4C46D0AC49E1Q30235427-445FEB4C-DF33-4155-AD7A-3C9BE5374D73Q34153204-C309F862-BF7A-4FB1-809B-71C52BC3C41BQ34207893-98035F36-5C7E-4416-B32B-20840EEC10B6Q34460281-1DC96B2F-B4B6-4CFD-A2FD-225640FB5893Q34954493-43AD54C3-D2E9-428B-84E9-FAE1BC5BFA46Q35913384-CF52EAED-00DD-46C7-80D8-F5C5A2C882D5Q36400904-0F0D1E63-EFA8-495A-A7D5-DAF2BFF18D8CQ37131701-4EE96825-3D2D-485E-A58B-272A76E6DB56Q37675494-2BD66F2D-15B6-4413-9506-4D5A5AF088F1Q37783344-312F0330-41C9-4D57-825E-028E4013ED78Q37856825-2C9A6AD8-07E8-4660-93C2-1ECF09EB1094Q38155513-40AB56CF-0E03-4B7C-8CF2-37843EC557DCQ38244965-0CB3F35E-9E59-47D3-ABD9-6CAD33EF7B09Q38367027-C249DD31-5B93-4635-828F-33AD4F8DB700Q38420005-2025A3B0-54DA-4E9B-8511-4708CB22DBE0Q41113380-16A2F3D3-8CB3-4795-94BA-E2DF1313A470Q41830068-BC3A8024-54B6-4108-8FEE-F376AAA9CF59Q44808185-E7038F7C-310C-48F2-8B87-ACA7782F0317Q46027563-94C3E058-73E1-4D3D-9DCC-7B92DB2C016BQ46142418-4B6B2E15-C0F2-4AFC-95C5-BDDF8A8D0040Q47285445-3C41596F-3B92-41E1-A8EA-900D8863FA95Q51827189-3BC2E938-1FF5-445C-8F67-174F6B1B07D5Q52682691-C9921DA1-EBB2-468D-BA88-D0EEB3148DA6Q54985330-56EFE9F4-87C4-459A-B467-E364538ED52AQ58407923-85085D5B-7DF8-49C8-9823-7895D819A6F7
P2860
Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.
@en
Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.
@nl
type
label
Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.
@en
Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.
@nl
prefLabel
Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.
@en
Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.
@nl
P2093
P50
P1476
Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.
@en
P2093
Claude Degott
Dominique Cazals-Hatem
Dominique Franco
Geneviève Monges
Hélène Blanché
Jacques Belghiti
Paulette Bioulac-Sage
P304
P356
10.1016/J.JHEP.2004.04.030
P577
2004-08-01T00:00:00Z